IONS vs PACS · rev $514.0M vs P/E 23, rev $5.29B
Ionis Pharmaceuticals Inc (IONS) versus PACS Group, Inc. (PACS) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
PACS Group, Inc. (PACS) is a medical care facilities company listed on NYSE.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported PACS revenue for 2025-12-31 was $5.29B. Net income was $191.5M. Revenue was up 29.3% from 2024-12-31 to 2025-12-31. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
IONS currently screens at market cap $12.28B. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
Not investment advice. Open the IONS and PACS stock pages for the full models.
Not investment advice.